CompletedPhase 2NCT03191162

Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.

Studying American trypanosomiasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Principal Investigator
Israel Molina, PhD, M.D
Hospital Universitario Vall d'Hebron Research Institute
Intervention
Benznidazole(drug)
Enrollment
238 enrolled
Eligibility
18 years · All sexes
Timeline
20172021

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03191162 on ClinicalTrials.gov

Other trials for American trypanosomiasis

Additional recruiting or active studies for the same condition.

See all trials for American trypanosomiasis

← Back to all trials